Trials / Recruiting
RecruitingNCT07207122
Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases
Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Sanmai Technologies PBC dba Sanmai · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of transcranial focused ultrasound neuromodulation in improving neural function, cognitive and behavioral performance, and quality of life for patients with neurodegenerative diseases.
Conditions
- Parkinson Disease
- Parkinson's Disease (PD)
- Parkinson's Disease Dementia (PDD)
- Parkinson's Disease Dementia
- Alzheimer's
- Alzheimer's Disease (AD)
- Mild Cognitive Impairment
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial focused ultrasound modulation administered to a region involved in disease pathology. | Using Sanmai's device to administer tFUS to regions of interest. |
Timeline
- Start date
- 2025-10-08
- Primary completion
- 2026-06-01
- Completion
- 2026-08-01
- First posted
- 2025-10-03
- Last updated
- 2025-10-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07207122. Inclusion in this directory is not an endorsement.